Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma

NCT03583424 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Hematopoietic Cell Transplantation Recipient
Recurrent Diffuse Large B-Cell Lymphoma
Recurrent Grade 1 Follicular Lymphoma
Recurrent Grade 2 Follicular Lymphoma
Recurrent Grade 3 Follicular Lymphoma
Recurrent Marginal Zone Lymphoma
Recurrent Non-Hodgkin Lymphoma
Refractory Diffuse Large B-Cell Lymphoma
Refractory Follicular Lymphoma
Refractory Marginal Zone Lymphoma
Refractory Non-Hodgkin Lymphoma
Refractory Transformed Indolent Non-Hodgkin Lymphoma

Interventions

DRUG: Carmustine
DRUG: Cytarabine
DRUG: Etoposide
PROCEDURE: Hematopoietic Cell Transplantation
DRUG: Melphalan
DRUG: Venetoclax

Sponsor

Ohio State University Comprehensive Cancer Center